Spring Bank Pharmaceuticals Nasdaq Listed Banner

Investor Overview

February 2017 Corporate Presentation

2015 Annual Report

  • Corporate Profile

    Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
    Read more

    $9.12 + 0.12
    Stock chart for: SBPH.O.  Currently trading at $9.12 with a 52 week high of $13.25 and a 52 week low of $6.31.
    02/27/172:56 p.m. ET
  • Upcoming Events

    Spring Bank Pharmaceuticals, Inc. at the Oppenheimer 27th Annual Healthcare Conference
    Tuesday, March 21, 2017 9:10 a.m. through Tuesday, March 21, 2017 9:40 a.m. ET

Latest News

Data provided by Nasdaq. Minimum 15 minutes delayed.